121 related articles for article (PubMed ID: 24842443)
1. ACP Journal Club. Early high-dose rosuvastatin prevented contrast-induced acute kidney injury in non-ST-elevation ACS.
Molnar AO; Garg AX
Ann Intern Med; 2014 May; 160(10):JC9. PubMed ID: 24842443
[No Abstract] [Full Text] [Related]
2. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).
Leoncini M; Toso A; Maioli M; Tropeano F; Villani S; Bellandi F
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):71-9. PubMed ID: 24076283
[TBL] [Abstract][Full Text] [Related]
3. Prevention: Rosuvastatin can prevent contrast-induced AKI.
Roberts A
Nat Rev Cardiol; 2013 Dec; 10(12):679. PubMed ID: 24165911
[No Abstract] [Full Text] [Related]
4. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy on Contrast-Induced Nephropathy and Myocardial Damage in Patients With Acute Coronary Syndrome Undergoing Coronary Intervention).
Toso A; Leoncini M; Maioli M; Tropeano F; Di Vincenzo E; Villani S; Bellandi F
JACC Cardiovasc Interv; 2014 Dec; 7(12):1421-9. PubMed ID: 25523533
[TBL] [Abstract][Full Text] [Related]
5. Do statins reduce the risk of contrast-induced acute kidney injury in patients undergoing coronary angiography or percutaneous coronary interventions?
Alpert MA
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):80-2. PubMed ID: 24076280
[No Abstract] [Full Text] [Related]
6. Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study.
Leoncini M; Toso A; Maioli M; Tropeano F; Badia T; Villani S; Bellandi F
Am Heart J; 2014 Nov; 168(5):792-7. PubMed ID: 25440809
[TBL] [Abstract][Full Text] [Related]
7. Impact of Rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography.
Abaci O; Arat Ozkan A; Kocas C; Cetinkal G; Sukru Karaca O; Baydar O; Kaya A; Gurmen T
Am J Cardiol; 2015 Apr; 115(7):867-71. PubMed ID: 25670636
[TBL] [Abstract][Full Text] [Related]
8. Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Patti G; Leoncini M; Toso A; Maioli M; Grieco D; Colonna G; Bellandi F; Di Sciascio G
Int J Cardiol; 2014 Jun; 174(2):440-1. PubMed ID: 24767765
[No Abstract] [Full Text] [Related]
9. ACP Journal Club: review: periprocedural high-dose statins reduce contrast-induced acute kidney injury after coronary angiography.
Bach RG
Ann Intern Med; 2015 Feb; 162(4):JC4. PubMed ID: 25686191
[No Abstract] [Full Text] [Related]
10. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
[TBL] [Abstract][Full Text] [Related]
11. [The PRATO-ACS study].
Marenzi G; Briguori C
G Ital Cardiol (Rome); 2013 Dec; 14(12):803-8. PubMed ID: 24336595
[No Abstract] [Full Text] [Related]
12. Statins for the prevention of contrast-induced acute kidney injury.
Ball T; McCullough PA
Nephron Clin Pract; 2014; 127(1-4):165-71. PubMed ID: 25343843
[TBL] [Abstract][Full Text] [Related]
13. The effect of rosuvastatin on platelet-leukocyte interactions in the setting of acute coronary syndrome.
Sexton TR; Wallace EL; Macaulay TE; Charnigo RJ; Evangelista V; Campbell CL; Bailey AL; Smyth SS
J Am Coll Cardiol; 2015 Jan; 65(3):306-7. PubMed ID: 25614429
[No Abstract] [Full Text] [Related]
14. Intravenous hydration (with or without rosuvastatin) should remain the cornerstone of the prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
Cecere N; Jadoul M; Labriola L
J Am Coll Cardiol; 2014 Jul; 64(3):332. PubMed ID: 25034074
[No Abstract] [Full Text] [Related]
15. Reply: Intravenous hydration (with or without rosuvastatin) should remain the cornerstone of the prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
Han Y
J Am Coll Cardiol; 2014 Jul; 64(3):332-3. PubMed ID: 25034073
[No Abstract] [Full Text] [Related]
16. The effects and mechanisms of high loading dose rosuvastatin therapy before percutaneous coronary intervention in patients with acute coronary syndrome.
Luo J; Li J; Shen X; Hu X; Fang Z; Lv X; Zhou S
Int J Cardiol; 2013 Sep; 167(5):2350-3. PubMed ID: 23194788
[No Abstract] [Full Text] [Related]
17. The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome.
Yun KH; Jeong MH; Oh SK; Rhee SJ; Park EM; Lee EM; Yoo NJ; Kim NH; Ahn YK; Jeong JW
Int J Cardiol; 2009 Nov; 137(3):246-51. PubMed ID: 18706705
[TBL] [Abstract][Full Text] [Related]
18. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
[TBL] [Abstract][Full Text] [Related]
19. Pre-procedural use of statins for all patients undergoing percutaneous coronary intervention.
Cay S
Int J Cardiol; 2011 Jan; 146(1):103-4. PubMed ID: 20947191
[No Abstract] [Full Text] [Related]
20. Plaque-stabilizing statin therapy prior to percutaneous transluminal angioplasty and stenting.
Spiegel R
Circ J; 2012; 76(6):1535; author reply 1536. PubMed ID: 22453007
[No Abstract] [Full Text] [Related]
[Next] [New Search]
